Skip to content

Prime Medicine, Inc.

PRME· NasdaqCore metricsCIK 1894562

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -9.66%
Market cap
$705.86M
181.92M shares
Filings
306
$4.21M
Q3 2026+55.3% FY25 yoy
-$39.04M
Q3 2026N/M FY25 yoy
-$39.93M
Q3 2026N/M FY25 yoy
-$121.00M
Q3 2026derivedN/M FY25 yoy
-$0.22
Q3 2026N/M FY25 yoy
$54.89M
Q3 2026−65.5% FY25 yoy
$705.86M
—
152.4×
83.7×
-23.67%
—

FY2025 figures · derived

Price

$3.881.27%$0.05past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$4.63MFY 2025
$5.21M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$4,632,000reported
FY 20242024-12-31$2,983,000reported
FY 20232023-12-31$0reported
FY 20222022-12-31$0reported
FY 20212021-12-31$0reported
FY 20202020-12-31$5,210,000reported

Biological products, except diagnostic substances

Prime Medicine, Inc. is the 68th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Prime Medicine, Inc. · CIK 1894562 · Engraved from SEC EDGAR